1. US National Library of Medicine, ‘Gastro Intestinal Tract (GI Tract).
  2. Boekema P.J. (1999): Coffee and gastrointestinal function: facts and fiction. A review.Scand J Gastroenterol, 230:35-9.
  3. Boekema P.J. et al. (2001): Functional bowel symptoms in a general Dutch population and associations with common stimulants.Neth J Med, 59(1):23-30.
  4. Haug T.T. et al. (1995): What Are the Real Problems for Patients with Functional Dyspepsia?Scan J Gastroenterol, 30(2):97-100.
  5. Nandurkar S. et al. (1998): Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection.Arch Intern Med, 158(13):1427-1433.
  6. Moayyedi P. et al. (2000): The Proportion of Upper Gastrointestinal Symptoms in the community Associated With Helicobacter pylori, Lifestyle Factors, and Nonsteroidal Anti-inflammatory Drugs.Am J Gastroenterol, 95(6):1448-1455.
  7. Boekema P.J. et al. (1999): Effect of coffee on gastroesophageal reflux in patients with reflux disease and healthy controls.Eur J Gastroenterol Hepatol, 11:1271-1276.
  8. Bolin T.D. et al. (2000): Esophagogastroduodenal Diseases and Pathophysiology, Heartburn: Community perceptions. J Gastroenterol Hepatol, 15:35-39.
  9. Dore M.P. et al. (2007): Diet, Lifestyle and Gender in Gastro-Esophageal Reflux Disease.Dig Dis Sci, 53(8):2027-2032.
  10. Pandeya N. et al. (2011): Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community. Diseases of the Esophagus, 25(7):573-83.
  11. Alsulobi A.M. et al. (2017): Gastroesophageal reflux disease among population of Arar City, Northern Saudi. Electronic Phys, 9(10)5499-5505.
  12. Nilsson M. et al. (2004): Lifestyle related risk factors in the aetiology of gastroesophageal reflux.Gut, 53:1730-1735.
  13. Zheng Z. et al. (2007): Lifestyle factors and Risks for Symptomatic Gastroeosophageal Reflux in Monozygotic Twins.Gastroenterol, 132:87-95.
  14. Kaltenbach T. et al. (2006): Review: sparse evidence supports lifestyle modifications for reducing symptoms of gastroesophageal reflux disease.Arch Intern Med, 166:965-971.
  15. Kim J. et al. (2013): Association between coffee intake and gastroesophageal reflux disease: a meta-analysis,Diseases of Esophagus, 27(4):311-317.
  16. Pehl C. et al. (1997): The effect of decaffeination of coffee on gastroesophageal reflux in patients with reflux disease.Alim Pharm Ther, 11:483-486.
  17. Rosenstock S. et al. (2003): Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2,416 Danish adults.Gut, 52:186-193.
  18. Shimamoto T. et al. (2013): No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan. PLoS One, 8(6):e65996.
  19. Aldoori W.H. et al. (1997): A Prospective Study of Alcohol, Smoking, Caffeine, and the Risk of Duodenal Ulcer in Men.Epidemiol, 4(8):420-424.
  20. Elta G.H. et al. (1990): Comparison of coffee intake and coffee-induced symptoms in patients with duodenal ulcer, nonulcer dyspepsia, and normal controls.Am J Gastroenterol, 85:1339-1342.
  21. Brown S.R. et al. (1990): Effect of coffee on distal colon function.Gut, 31:450-453.
  22. Rao S.S.C. et al. (1998): Is coffee a colonic stimulant.Eur J Gastroenterol Hepatol, 10:113-118.
  23. Sloots C.E.J. et al. (2005): Stimulation of defecation: Effects of coffee use and nicotine on rectal tone and visceral sensitivity.Scan J Gastroenterol, 40:808-813.
  24. Simren M. et al. (2001): Food-Related Gastrointestinal Symptoms in the Irritable Bowel Syndrome.Digestion, 63:108-115.
  25. Barthel C. et al. Patients perception on the impact of coffee consumption in inflammatory bowel disease: friend or foe? Nutr J, 14:78.
  26. Leitzmann M.F. et al. (1999): A prospective study of coffee consumption and risk of symptomatic gallstone disease in men.JAMA, 281:2106-2112.
  27. Leitzmann M.F. et al. (2002): Coffee intake is associated with lower risk of symptomatic gallstone disease in women.Gastroenterol, 123:1823-1830.
  28. Ruhl C.E. et al. (2000): Association of coffee consumption with gallbladder disease. Am J Epidemiol, 152:1034-8.
  29. Douglas B.R. et al. (1990): Coffee stimulation and cholecystokinin release and gallbladder contraction in humans. Am J Clin Nutr 52:553-6.
  30. Saab S. et al. (2014): Impact of coffee on liver disease a systematic review. LiverInt, 34(4):495-504.
  31. Loomis D. et al. (2016): Carcinogenicity of drinking coffee, maté, and very hot beverages.The Lancet Oncology, 17(7):877-878.
  32. Lee H.S. and O’Mahony M. (2002): At What Temperatures Do Consumers Like to Drink Coffee?: Mixing Methods. J Fd Sci, 67(&):2774-2777
  33. Brown F. and Diller K.R. (2008): Calculating the optimum temperature for serving hot beverages. Burns, 34(5):648-54.
  34. Botelho F. et al. (2006): Coffee and gastric cancer: systematic review and meta-analysis. Cad Saude Publica, 22:889–900.
  35. Sanikini H. et al. (2015): Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: results from EPIC cohort study. Int J Cancer, 136(6):E720-30.
  36. Yu X. et al. (2011): Coffee consumption and risk of cancers: a meta-analysis of cohort studies.BMC Cancer, 15:11-96.
  37. Tavani A. et al. (2004): Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies 1990-2003. Cancer Causes Control, 15:743-57.
  38. Giovannucci E. (1998): Meta-analysis of coffee consumption and risk of colorectal cancer.Am J Epidemiol, 147:1043–52.
  39. Galeone C. et al. (2010): Coffee consumption and risk of colorectal cancer: a meta-analysis of case–control studies.Cancer Causes Control, 21:1949-59.
  40. Nie J.-Y. et al. (2017): Beverage consumption and risk of ulcerative colitis: A systematic review and meta-analysis of epidemiological studies. Med, 96(49):e9070.
  41. Larsson S.C. et al. (2007): Coffee consumption and liver cancer: a meta-analysis.Gastroenterol, 132:1740-1745.
  42. Bravi F. et al. (2007): Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.Hepatol, 46:430-435.
  43. WCRF (2007): ‘Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective’ Available at:
  44. Luo J. et al. (2007): Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev, 16:542-8.
  45. Dong J. et al. (2011): Coffee drinking and pancreatic cancer risk: a meta-analysis,World J Gastroenterol, 17(9):1204-10.
  46. Turati F. et al. (2011): A meta-analysis of coffee consumption and pancreatic cancer.Annals Oncol, 23(2):311-8.
  47. Turati F. et al. (2011): Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: a pooled-analysis of two Italian case-control studies. Eur J Cancer Prevention, 20(4):287–292.

This information is intended for Healthcare professional audiences.
Please consider the environment before printing.